Massivemarkets

SEC Form 4

uniQure N.V. (QURE) insider trading

In the 12 months to Nov 21, 2026, 6 QURE insiders reported open-market sales of $17.9M across 14 filings; no open-market purchases were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$17.9M
14 filings · 6 insiders
Open-market purchases
$0
0 filings
Pre-arranged sales (10b5-1)
14 of 14
All $17.9M sold was pre-arranged

Who traded QURE, and when

  • Sale
  • Sale, pre-arranged (10b5-1)

QURE daily close from Nov 21, 2025 to Nov 20, 2026, between $9.03 and $51.05, last $19.35. 14 sale and 0 purchase filings by 6 insiders, marked at their filing dates. Matthew C. Kapusta, CEO, Managing Director: sold $12.1M across 3 filings, first filed Jun 22, 2026, last Jul 7, 2026. Walid Abi-Saab, Chief Medical Officer: sold $2.5M across 2 filings, first filed May 12, 2026, last Jul 2, 2026. Jack Kaye, Director: sold $1.5M across 4 filings, first filed Jan 12, 2026, last Jul 2, 2026. Robert Gut, Director: sold $827.2K across 2 filings, first filed Jan 14, 2026, last Jun 12, 2026. Madhavan Balachandran, Director: sold $805.0K across 2 filings, first filed Jun 17, 2026, last Jun 22, 2026. David D. Meek, Director: sold $193.0K across 1 filing, first filed Nov 10, 2026, last Nov 10, 2026.

Largest mark · tap a row for others

Matthew C. Kapusta · CEO, Managing Director

Filing 1 of 2 within a week · $11,142,786 total

Sale $9,371,612

206,100 shares

Filed Jun 22, 2026 · traded Jun 17

Pre-arranged (10b5-1) · close on filing date $44.39

QURE daily closelast $19.35

Matthew C. Kapusta · CEO, Managing Director

$12.1M sold

Walid Abi-Saab · Chief Medical Officer

$2.5M sold

Jack Kaye · Director

$1.5M sold

Robert Gut · Director

$827.2K sold

Madhavan Balachandran · Director

$805.0K sold

David D. Meek · Director

$193.0K sold
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

14 filings in the last 12 months
Other insider activity (not market trades) · 50 records
  • Option exercises17 records
  • Tax withholding (sold to cover)20 records
  • Grants and awards13 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.

Frequently asked questions

Has uniQure N.V.'s CEO sold stock?

Yes. Matthew C. Kapusta (CEO) sold 262,594 shares ($12.1M) between Jun 2026 and Jul 2026, all under a pre-arranged 10b5-1 plan.

How current is QURE’s insider data?

These are QURE Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track QURE insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for QURE every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.